Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Istituto di Ricovero e Cura a Carattere Scientifico di natura pubblica
Welcome,         Profile    Billing    Logout  
 0 Trials 
9 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Valenti, Luca
NATiV3, NCT04849728: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( )

Recruiting
3
1000
Europe, Canada, US, RoW
IVA337, Lanifibranor, Placebo
Inventiva Pharma
NASH - Nonalcoholic Steatohepatitis
09/25
09/26
HORIZON, NCT05583344 / 2022-002538-14: Phase 2b Study of GSK4532990 in Adults With NASH

Active, not recruiting
2
284
Europe, Canada, Japan, US, RoW
GSK4532990, Placebo
GlaxoSmithKline, GlaxoSmithKline Research & Development Limited
Nonalcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease
01/26
04/27
PERSPECTIVE, NCT06523179: Evaluation of Risk of hEpatocellular Carcinoma

Recruiting
N/A
500
Europe
quantify the impact of genetic risk factors
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
NASH, HCC, Genetic Predisposition
01/22
12/25
NCT06566105: The Liver BIoBank Lombardia of Fatty Liver

Recruiting
N/A
2500
Europe
precision medicine approach
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
NAFLD, Precision Medicine, Cardiovascular Diseases
06/24
12/32
NCT06311396: Development of a Neuronal Microscope

Active, not recruiting
N/A
30
Europe
genetic model
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Hepatic Carcinoma
01/24
06/25
REASON, NCT06856252: Human Liver ORganoids as a Model to Study the Development of Non-Alcoholic SteatOhepatitis (NASH)

Recruiting
N/A
60
Europe
Liver resection to isolate cells
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
NAFLD
07/24
06/26
NCT06332677: Target of Suv420h1/2 in Hepatocytes

Recruiting
N/A
260
Europe
the main genes and expression by comparing the transcriptomic lipidomic profile
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
NAFLD
02/26
02/27
CV-PREVITAL, NCT05339841: Italian Digital Primary Cardiovascular Prevention Study

Active, not recruiting
N/A
27520
Europe
Mobile health application, mHealth app
Centro Cardiologico Monzino, Istituto Auxologico Italiano, Humanitas Hospital, Italy, Istituto Di Ricerche Farmacologiche Mario Negri, IRCCS Multimedica, Neuromed IRCCS, IRCCS Policlinico S. Donato, Istituti Clinici Scientifici Maugeri SpA, The Mediterranean Institute for Transplantation and Advanced Specialized Therapies, Ospedale Policlinico San Martino, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Fondazione IRCCS Policlinico San Matteo di Pavia, IRCCS San Raffaele Roma, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Healthy Population
06/29
12/29
NCT04442334: The European NAFLD Registry

Recruiting
N/A
10000
Europe
Newcastle University, Newcastle-upon-Tyne Hospitals NHS Trust, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Institute of Cardiometabolism and Nutrition, France, University of Cambridge, Örebro University, Sweden, University of Bern, University of Oxford, University of Turin, Italy, University of Angers, University Hospital, Antwerp, Linkoeping University, University of Helsinki, UMC Utrecht, National and Kapodistrian University of Athens, University of Lisbon, University of Milan, University of Palermo, Catholic University of the Sacred Heart, Wuerzburg University Hospital, RWTH Aachen University, University of Nottingham, Medical University of Vienna, University of Birmingham, University of Florence, Assistance Publique - Hôpitaux de Paris, University Medical Center Mainz
NAFLD, NASH, NASH - Nonalcoholic Steatohepatitis, Fibrosis, Liver, Steatosis of Liver, Hepatocellular Carcinoma, Cardiovascular Diseases, Type 2 Diabetes, Dyslipidaemia, Hypertension, Obesity, Other Associated Comorbidities
12/30
12/30
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Valenti, Luca
NATiV3, NCT04849728: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( )

Recruiting
3
1000
Europe, Canada, US, RoW
IVA337, Lanifibranor, Placebo
Inventiva Pharma
NASH - Nonalcoholic Steatohepatitis
09/25
09/26
HORIZON, NCT05583344 / 2022-002538-14: Phase 2b Study of GSK4532990 in Adults With NASH

Active, not recruiting
2
284
Europe, Canada, Japan, US, RoW
GSK4532990, Placebo
GlaxoSmithKline, GlaxoSmithKline Research & Development Limited
Nonalcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease
01/26
04/27
PERSPECTIVE, NCT06523179: Evaluation of Risk of hEpatocellular Carcinoma

Recruiting
N/A
500
Europe
quantify the impact of genetic risk factors
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
NASH, HCC, Genetic Predisposition
01/22
12/25
NCT06566105: The Liver BIoBank Lombardia of Fatty Liver

Recruiting
N/A
2500
Europe
precision medicine approach
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
NAFLD, Precision Medicine, Cardiovascular Diseases
06/24
12/32
NCT06311396: Development of a Neuronal Microscope

Active, not recruiting
N/A
30
Europe
genetic model
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Hepatic Carcinoma
01/24
06/25
REASON, NCT06856252: Human Liver ORganoids as a Model to Study the Development of Non-Alcoholic SteatOhepatitis (NASH)

Recruiting
N/A
60
Europe
Liver resection to isolate cells
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
NAFLD
07/24
06/26
NCT06332677: Target of Suv420h1/2 in Hepatocytes

Recruiting
N/A
260
Europe
the main genes and expression by comparing the transcriptomic lipidomic profile
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
NAFLD
02/26
02/27
CV-PREVITAL, NCT05339841: Italian Digital Primary Cardiovascular Prevention Study

Active, not recruiting
N/A
27520
Europe
Mobile health application, mHealth app
Centro Cardiologico Monzino, Istituto Auxologico Italiano, Humanitas Hospital, Italy, Istituto Di Ricerche Farmacologiche Mario Negri, IRCCS Multimedica, Neuromed IRCCS, IRCCS Policlinico S. Donato, Istituti Clinici Scientifici Maugeri SpA, The Mediterranean Institute for Transplantation and Advanced Specialized Therapies, Ospedale Policlinico San Martino, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Fondazione IRCCS Policlinico San Matteo di Pavia, IRCCS San Raffaele Roma, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Healthy Population
06/29
12/29
NCT04442334: The European NAFLD Registry

Recruiting
N/A
10000
Europe
Newcastle University, Newcastle-upon-Tyne Hospitals NHS Trust, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Institute of Cardiometabolism and Nutrition, France, University of Cambridge, Örebro University, Sweden, University of Bern, University of Oxford, University of Turin, Italy, University of Angers, University Hospital, Antwerp, Linkoeping University, University of Helsinki, UMC Utrecht, National and Kapodistrian University of Athens, University of Lisbon, University of Milan, University of Palermo, Catholic University of the Sacred Heart, Wuerzburg University Hospital, RWTH Aachen University, University of Nottingham, Medical University of Vienna, University of Birmingham, University of Florence, Assistance Publique - Hôpitaux de Paris, University Medical Center Mainz
NAFLD, NASH, NASH - Nonalcoholic Steatohepatitis, Fibrosis, Liver, Steatosis of Liver, Hepatocellular Carcinoma, Cardiovascular Diseases, Type 2 Diabetes, Dyslipidaemia, Hypertension, Obesity, Other Associated Comorbidities
12/30
12/30

Download Options